Newron Pharmaceuticals S.p.A. announced the appointment of Ulrich Köstlin as non-executive director and Chairman, Robert Leslie Holland as non-executive director, and Bo Jesper Hansen as non-executive director.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.08 CHF | -4.91% | -4.00% | +103.64% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+103.64% | 217M | |
-3.15% | 89.69B | |
+2.50% | 41.34B | |
-12.01% | 33.72B | |
+62.74% | 26.11B | |
-19.79% | 14.63B | |
-8.58% | 12.84B | |
-12.34% | 11.66B | |
-43.92% | 11.52B | |
+4.27% | 8.92B |
- Stock Market
- Equities
- NWRN Stock
- News Newron Pharmaceuticals S.p.A.
- Newron Pharmaceuticals S.p.A. Announces Board Appointments